This site is intended for healthcare professionals only
LoginRegister
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationNPPA Panel Defers Biological E's Pneumonia Vaccine Price Exemption, Seeks Clarification
Aurobindo Pharma Extends Timeline to Acquire 26% in Swarnaakshu SolarAurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line
Pill form of Wegovy gets USFDA approval for weight lossNovo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle
Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035CDSCO Panel Withholds Nod for Syngene's Pegfilgrastim Trial, Seeks Additional Data
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived
18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS
No Generics for AbbVies Rinvoq Until 2037, Analysts See Multi-Billion Dollar BoostAbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh
GSK Exdensur wins USFDA approval for severe asthmaGSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031
KEA Revises KCET 2026 Pharmacy Exam Dates, Applications Open Till March 15Pharmacy Colleges in Trouble: Maharashtra Cracks Down on Institutions Failing PCI Standards
USFDA Reappoints Vinay Prasad to Top Medical and Scientific RoleTop USFDA vaccine official Vinay Prasad exits agency
Akums Drugs & Pharma appoints Tarun Kapoor as CIOAkums Drugs & Pharma appoints Tarun Kapoor as CIO
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesNPPA Regulated Prices of 2,295 Essential Drugs Over Five Years, Says Govt
X